100 related articles for article (PubMed ID: 9672793)
1. Prolongation of corneal allograft survival by an interleukin-2-immunoglobulin fusion protein in mice.
Zhang EP; Pohl T; Bulfone-Paus S; Wachtlin J; Kunzendorf U; Hoffmann F
Graefes Arch Clin Exp Ophthalmol; 1998 Jul; 236(7):486-92. PubMed ID: 9672793
[TBL] [Abstract][Full Text] [Related]
2. Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.
Kunzendorf U; Pohl T; Bulfone-Paus S; Krause H; Notter M; Onu A; Walz G; Diamantstein T
J Clin Invest; 1996 Mar; 97(5):1204-10. PubMed ID: 8636431
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of corneal allograft reaction by CTLA4-Ig.
Hoffmann F; Zhang EP; Pohl T; Kunzendorf U; Wachtlin J; Bulfone-Paus S
Graefes Arch Clin Exp Ophthalmol; 1997 Aug; 235(8):535-40. PubMed ID: 9285225
[TBL] [Abstract][Full Text] [Related]
4. Foxp3-expressing sensitized Teff cells prolong survival of corneal allograft in corneal allograft transplantation mouse model.
Zhao J; Li Z; Wang L; Liu J; Wang D; Chen G; Wang Q; Zhang H
Transpl Immunol; 2015 Nov; 33(3):192-7. PubMed ID: 26419203
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of costimulatory pathway modulation on corneal allograft survival.
Watson MP; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
[TBL] [Abstract][Full Text] [Related]
6. The effect of oral immunization on corneal allograft survival.
He YG; Mellon J; Niederkorn JY
Transplantation; 1996 Mar; 61(6):920-6. PubMed ID: 8623161
[TBL] [Abstract][Full Text] [Related]
7. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
8. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
10. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
Shi W; Chen M; Xie L
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
[TBL] [Abstract][Full Text] [Related]
11. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
Matoba AY; Peeler JS; Niederkorn JY
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
[TBL] [Abstract][Full Text] [Related]
12. An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppression.
Bulfone-Paus S; Rückert R; Krause H; von Bernuth H; Notter M; Pohl T; Tran TH; Paus R; Kunzendorf U
Transplantation; 2000 Apr; 69(7):1386-91. PubMed ID: 10798759
[TBL] [Abstract][Full Text] [Related]
13. Suppression of allograft rejection with anti-alphabeta T cell receptor antibody in rat corneal transplantation.
Yamagami S; Tsuru T; Ohkawa T; Endo H; Isobe M
Transplantation; 1999 Feb; 67(4):600-4. PubMed ID: 10071034
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506.
Yamagami S; Isobe M; Yamagami H; Hori J; Tsuru T
Transplantation; 1997 Jul; 64(1):42-8. PubMed ID: 9233699
[TBL] [Abstract][Full Text] [Related]
15. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
Joo CK; Pepose JS; Stuart PM
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
[TBL] [Abstract][Full Text] [Related]
16. The effect of corticosteroid and cyclosporin A on murine corneal allograft rejection.
Zhang EP; Schulte F; Bulfone-Paus S; Hoffmann F
Graefes Arch Clin Exp Ophthalmol; 2000 Jun; 238(6):525-30. PubMed ID: 10943679
[TBL] [Abstract][Full Text] [Related]
17. Effect of local macrophage depletion on cellular immunity and tolerance evoked by corneal allografts.
Slegers TP; van der Gaag R; van Rooijen N; van Rij G; Streilein JW
Curr Eye Res; 2003 Feb; 26(2):73-9. PubMed ID: 12815525
[TBL] [Abstract][Full Text] [Related]
18. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.
He Y; Mellon J; Apte R; Niederkorn JY
Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3218-25. PubMed ID: 7913917
[TBL] [Abstract][Full Text] [Related]
19. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
[TBL] [Abstract][Full Text] [Related]
20. J2 prolongs the corneal allograft survival through inhibition of the CD4+ T cell-mediated response in vivo.
Xiao H; Zhang H; Yu ZY; Zhang L; Yu M; Huang YF; Li S; Shen BF; Li Y
Transpl Immunol; 2007 Nov; 18(2):130-7. PubMed ID: 18005857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
